Date2020. 11.25(Wed)
PlaceLotte Hotel Seoul, Emerald Rm,(2F) Seoul,Korea & Live Streaming on YouTube
OrganizersNews1
08:30~09:00 |
Registration |
|
09:00~09:30 |
Opening Greeting & Congratulatory message |
Baik Kyu Lee CEO, News1 Gang Lip KimMinister, Ministry of Food and Drug Safety Byung Seon Jeong 1st Vice-Minister, Ministry of Science and ICT BG Rhee Chairman, News1 Bioleader’s club, Chairman, Council for Advanced Regenerative Medicine, CEO, SCM Lifescience |
09:30~10:15 |
Keynote SpeechSeeking oppertunities in risk, K-Bio in the World Pendemics |
Jung Jin SeoChairman, Celltrion Group |
10:15~10:45 |
Session1Covid vaccines: Approaching the end of beginning |
David Flores BioCentury President & CEO |
10:45~11:30 |
Discussion The possibility of success in developing COVID-19 vaccine and treatment worldwide...behind stories of Pfizer and Moderna |
David Flores BioCentury President & CEO Cameron WolfeAssociate Professor, Duke University Joseph P. McMenaminExecutive Vice President, W Medical Strategy Group Andy Jang Co founder & CEO, Starassets Investment |
11:30~12:00 |
IR session Covid-19 cure & vaccine |
GC Greencross (Plasma therapy) Ybiologics (Antibody) |
12:00~12:30 |
Session2Hepatitis C...the story of developing a cure |
Dimitri Semizarov, PhDDirector, Global Medical Affairs Hepatology, Abbvie Matthew Krzywosz, PharmDAssociate Scientific Director, Global Medical Affairs Hepatology, Abbvie |
12:30~13:30 |
Lunch |
|
13:30~14:00 |
Session3CRO-CDO-CMO: End to End Service Provider |
Wan Goo HwangManaging Director, Samsung Biologics |
14:00~14:30 |
IR sessionCovid-19 diagnosis |
Optolane (Diagnostic kit) PCL (Diagnostic kit) |
14:30~14:40 |
Coffee Break |
|
14:40~15:55 |
IR sessionCancer & Orphan drug |
Genome & Company HaplnScience Tiumbio Toolgen Abionbio |
Closing |
※ The above schedule is subject to change.